Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site
The structure was published by Jahnke, W., Grotzfeld, R.M., Pelle, X., et al., Furet, P., Mestan, J., and Marzinzik, A.L., in 2010 in a paper entitled "Binding or bending: distinction of allosteric Abl kinase agonists from antagonists by an NMR-based conformational assay." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 1.95 Å and deposited in 2010.
The experimental data on which the structure is based was also deposited.
This PDB entry contains multiple copies of the structure of Tyrosine-protein kinase ABL1.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule has more than one probable quaternary state observed. For more details see the quaternary structure page.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: